Latest Blogs

Nov 24, 2021
Transitions are hard in a medical career, especially as the holidays approach, but you can offer colleagues the gift of a listening ear and a safe space. 
Nov 16, 2021
In an original poem, Dr. Alankrita Taneja evokes a lesson learned from her patients on "the hard spiritual truth about living each day and each moment as it comes while surrendering control of the outcome."  
Nov 03, 2021
ASCO president Dr. Everett E. Vokes and Nominating Committee chair Dr. Sharon H. Giordano have a call to action for all voting-eligible members.
Nov 02, 2021
We should start to implement and teach telemedicine earlier in training, so that new trainees can have all the tools needed to navigate and use this modality without any fear or limitation, said Dr. Tarek Haykal.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine at Brown University, director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Aug 14, 2011
One of the interests I have developed over time is in the arena of cancer survivorship, specifically female sexual heath after cancer and its treatment. Having worked at Memorial Sloan-Kettering both as a fellow and as a junior faculty member, I worked closely with colleagues in Gynecology,...
Jul 19, 2011
I recently returned from the semi-annual meeting of the Gynecologic Oncology Group, where the charge is to develop and test new treatment strategies in gynecologic malignancies. In the time I have been involved with the group, I have witnessed paradigm shifts in...

Pages